Physician profile
William E Snyder
NPI 1669451753
$13,948.90
in general payments reported to CMS, 2019-2025
10 companies · $37.98 in 2025
The $37.98 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $242 · 2020: $8,093 · 2021: $198 · 2022: $60.80 · 2023: $233 · 2024: $5,083 · 2025: $37.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,000 · Food and Beverage: $335 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,000.00 |
| Food and Beverage | $334.53 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Choice Spine, LLC | $13,000.00 | 2020-2024 | Tiger Shark System |
| Medtronic USA, INC. | $290.12 | 2019-2020 | |
| Stryker Corporation | $243.08 | 2021-2022 | |
| Zimvie INC. | $199.41 | 2023 | |
| Medtronic, INC. | $54.12 | 2022-2025 | Unid_pass |
| Cerapedics INC. | $49.39 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Djo, LLC | $47.75 | 2023-2024 | Cmf |
| Pfizer INC. | $27.97 | 2019 | |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Boston Scientific Corporation | $17.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Snyder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.